Create a Profile
What’s Next in the Fight Against COVID-19?
We know that any decision about you and your child’s health is important.
The NextCOVE Study is researching an investigational vaccine that may help protect against multiple variants of COVID-19 for individuals ages 12 to 17 who have received a COVID-19 vaccine and individuals ages 18 and older who have received a COVID-19 vaccine and at least 1 booster dose of a COVID-19 vaccine.
Contact the participating clinical trial site to find out more and see if you or your child can take part today.
Create a Profile
Get In Touch Mobile
Study Locations
Atlanta Clinical Research Centers | Accel Research Sites Network
5671 Peachtree Dunwoody Road
Atlanta, Georgia 30342
Atlanta, Georgia 30342
Neurology and Neurodiagnostics of Alabama | Accel Research Sites Network
1000 Southlake Park
Hoover, Alabama 35244
Hoover, Alabama 35244